Apple Launches Online Store in Saudi Arabia, Plans Physical Expansion by 2026
In addition to product availability, Apple's Saudi-specific website will offer dedicated local features such as Arabic language support and Arabic engraving options for selected products. The Apple Store app is also being introduced in the region, enhancing the digital shopping experience for Saudi users.
Until now, customers in Saudi Arabia have had to rely on authorized resellers to purchase Apple products. While the App Store has been accessible in the region for years, the launch of the full online retail experience brings Saudi consumers in line with Apple's global customer base. The move not only represents increased access to Apple's ecosystem but also highlights the company's interest in building a closer relationship with the country's tech-savvy population.
The retail expansion into Saudi Arabia comes as part of a broader wave of investment by major U.S. tech companies in the kingdom. Over recent months, firms like Amazon, Google, Nvidia, and AMD have entered multi-billion-dollar partnerships with Saudi-backed ventures, signaling an industry-wide trend of deeper engagement with the region.
One significant development occurred during U.S. President Donald Trump's May visit to the Middle East. On that occasion, Crown Prince Mohammed bin Salman announced the creation of Humain, an artificial intelligence company owned by Saudi Arabia's Public Investment Fund. On the same day, several major U.S.-based technology companies announced large-scale collaborations with the new AI firm.
Despite this influx of capital and corporate partnerships, Saudi Arabia remains under scrutiny for its human rights record. However, these concerns have not slowed the pace of tech expansion into the region, with companies often citing strategic growth opportunities and access to an increasingly digital population.
Apple's entry into Saudi Arabia's direct-to-consumer market reflects a long-term vision to grow its footprint in the Gulf. The new online store provides Saudi customers with an opportunity to engage more directly with Apple's product ecosystem and services, while future physical stores promise a more immersive retail experience akin to the company's global outlets.
With tech giants racing to tap into the region's economic diversification and digital transformation initiatives, Apple's Saudi debut signals that the kingdom is fast becoming a key player in the global tech landscape.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Economic Times
22 minutes ago
- Economic Times
The Hundred looking to feed off IPL's 'phenomenal growth' after drawing Indian investment
The investment of four IPL owners into The Hundred will enable the England and Wales Cricket Board-backed event to grow rapidly and learn immensely from the skills possessed by the top minds working for the world's biggest T20 league. Out of the eight teams in the 100-ball competition, four will be partially owned by owners of Mumbai Indians, Sunrisers Hyderabad, Lucknow Super Giants and Delhi Capitals (only GMR group involved). After a long delay, the ECB finalised the deals with the IPL and other investors on Wednesday. Reliance Group, which will own 49 percent of the London-based Oval franchise, and Trent Rockets are yet to close agreements with the ECB. "It's brilliant. You look at what the IPL has done, forget cricket, in sport in general, the growth it's achieved in 18 short years. It's nothing short of phenomenal," said Vikram Banerji, Managing Director of The Hundred, in response to a PTI query on Thursday. "So the growth and the learnings, both on the field and off the field, that they can bring into this tournament, with the balance of the other investors that we've got from America and wherever else, I'm really excited about that side of things, about the skill sets that are now coming into English cricket," he said. The deal will take effect from 2026 season and the investors will take operation control of the franchise from October 1, 2025. Asked about the reason for the delay in closing the agreement with the Reliance-backed Oval franchise and Trent Rockets, Banerji said: "Right at the start we offered all the investors the opportunity to sign and close immediately whenever the legals were all done and have some involvement in this year. "On the whole, it's been run as it was, or close formally at the end of the season, early October, when they close formally, when they take operational control of the name of the brand. So those two chose that months ago. "With Trent Rockets, it's documents were signed and all the rest of it fully there. With the Oval Invincibles, there's three things left on their venue hire stuff that they're working through. They're small things, it'll be a matter of weeks, and that'll get signed out." Banerji and the rest of the stakeholders will soon have a meeting with the new investors for the tournament operations from 2026 onwards. Barring The Hundred, all leagues including the IPL are being played in the T20 format. Is there an inclination from the IPL owners to switch to the standard T20 format from the current 100-ball a side format? "I think you have to look at what works in this country. There have been some discussions around kind of it works elsewhere, but in this country, the format has provided us with some really interesting things, especially from a broadcast perspective in terms of the reach it's provided and that ability to create a new crowd. "At the moment, it's the 100 format, and that will remain for now. But let's see where we get to in a month," said Banerji, who added the participation of active Indian players remains off the card despite the IPL investment into the competition. Sitting alongside Banerji, ECB chief executive Richard Gould, was also asked about the participation of Pakistan players in The Hundred in light of Indian investment. No Pakistan player was picked in the 2025 draft for different reasons. Gould asserted the ECB will take action if the owners are found to be discriminatory in player selection irrespective of his nationality. "We would expect players of all nations to be selected for all teams. I haven't had the need to have any discussion at this point (with new investors)." So is the latest draft just a coincidence? "I don't, I don't know. But we have not had any discussions with the owners at this point. But, we've got very clear anti-discrimination policies within cricket in England. And if those are, if those are not adhered to, our cricket regulator will take action," said Gould. Now that the deals are done, the ECB expects the change in name of at least three teams backed by IPL team owners including Reliance, RPSG and GMR. The sale of stakes have catapulted the valuation of teams to over 975 million pounds with more than 500 million pounds set to be invested in English cricket.
Indian Express
25 minutes ago
- Indian Express
Microsoft enters $4 trillion market cap, joins Nvidia in exclusive club
Microsoft became the second company to reach a $4 trillion market valuation on Thursday, after its blockbuster earnings boosted shares by nearly 4.5 per cent, lifting its intraday valuation to $4.01 trillion. The company's stock has climbed about 28 per cent since January and rebounded nearly 50 per cent from April lows triggered by Trump's tariff offensive. The surge follows a strong quarterly report on Wednesday. Microsoft forecast a record '$30 billion in capital spending' for the current fiscal first quarter to power its AI growth and reported robust sales in its Azure cloud business. Analysts noted that Microsoft's Copilot AI is driving 'meaningful growth' in the Microsoft 365 enterprise suite. The milestone comes just 18 months after it hit the $3 trillion mark, and a few weeks after Nvidia became the first company to top $4 trillion. Apple was last valued at $3.12 trillion. Recent breakthroughs in US trade talks ahead of Trump's August 1 tariff deadline have also buoyed stocks, pushing the S&P 500 and Nasdaq to record highs.
Economic Times
25 minutes ago
- Economic Times
Healthcare costs in US to shoot up following Trump tariff on Indian goods: Industry experts
Agencies Representative Image New Delhi: Healthcare costs in the US will increase following the imposition of sweeping 25 per cent tariff plus an unspecified penalty on Indian goods, experts from pharmaceuticals and medical devices industry said on Thursday. President Donald Trump on Wednesday announced the imposition of a 25 per cent tariff on all goods coming from India starting August 1, plus an unspecified penalty for buying Russian crude oil and military equipment. Profits for Indian pharmaceutical firms may decline and research and development may stagnate. However, for the medical devices sector as long as the gap between duty on China and India is over 15- 20 per cent, there are positive prospects for exports to the US, according to experts. "India isn't just a key supplier of generics to the US. We are a part of the backbone of affordable global healthcare. These duties may interrupt the smooth trade flow, inflate US drug costs, stall treatments, and put even greater pressure on American healthcare budgets," OmniActive Health Technologies Executive Chairman and MD Sanjaya Mariwala said. On the other hand, he said, "Back home, the profits for Indian pharmaceutical firms may decline, and R&D may stagnate, slowing down innovation and stalling new drug clearances." AiMeD (Association of Indian Medical Device Industry) Forum Coordinator Rajiv Nath said, "Duties impact for Indian medical devices sector has to be seen from relative competitiveness - as long as duty gap between Chinese versus Indian is over 15- 20 per cent, we have positive prospects to export to USA and even put production lines in USA." Currently Indonesia and Vietnam have lower duties by 6 per cent. So for products made there they will possibly enjoy a price competitive advantage over India, he added. Stating that clarity will come after August 12 as then duties on Chinese goods will be clear, Nath said, "They were increased to over 50 per cent but temporarily reduced to 30 per cent. If post-August duties on Chinese medical devices revert to over 50 per cent and on Indian at 25 per cent, the export prospects versus China are in our favour..." He further said, "Suffice to say that whatever is the final duty that is finally announced on medical devices, if it's at least 15-20 per cent lower than applicable duty rates by US onto China then there is a strong opportunity for Indian medical devices to increase their exports to US market, if they are able to absorb the excessive high cost of regulatory approval of USFDA for market entry and find that these costs to export are sustainable over the years." However, he said, the government of India and manufacturers will need to work to improve India's competitiveness "so that we can offset the 6 per cent disadvantage over Indonesian and Vietnam competitors". Grant Thornton Bharat Partner and Tax Controversy Management Leader Manoj Mishra pointed out that the strong language used by President Trump and ongoing investigations into drug imports mean that the risk is not over yet. "Indian pharma companies should stay prepared for possible changes, especially if sector-specific duties are introduced later. That said, these tariffs are likely to be in place only for a short period, as both countries are expected to fast-track discussions for a Bilateral Trade Agreement. A balanced and stable trade deal will be key to protecting long-term interests of the sector," he noted. Similarly, Choice Broking Equity Research Analyst- Pharma Sector, Maitri Sheth said the US remains heavily reliant on India for its pharmaceutical needs, with about 50 per cent of generic drugs sourced from India. "Given the critical nature of healthcare and already elevated healthcare costs in the US, we view the likelihood of material near-term tariffs on pharma as low," Sheth added. While the headline risk persists, the structural dependence on Indian pharma and the cost sensitivity of the US healthcare system provide a strong case against aggressive tariff action on the sector, Sheth added. Medical Technology Association of India (MTaI) Chairman Pavan Choudary said President Trump's is "troubling and seems economically shortsighted and strategically misguided".
